Vaccinium myrtillus as an antidiabetic medicinal plant - Research through the ages

Pharmazie

Volumn 65, Issue 5, 2010, Pages 315-321

  Helmstadter A ^a,b   Schuster, N ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b ABDA Bundesvereinigung Deutscher Apothekerverbande   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALLOXAN; AMMONIUM SULFATE; AMYLASE INHIBITOR; ANTIDIABETIC AGENT; DECAMETHYLENEDIGUANIDINE DIHYDROCHLORIDE; GALLIC ACID DERIVATIVE; GLUCOSE; GUANIDINE DERIVATIVE; HYDROCHLORIC ACID; HYDROQUINONE; INSULIN; MYRTILLIN; MYRTOMEL; NEOMYRTILLIN; NORISDIABET; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHYTOHORMONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VACCINIUM MYRTILLUS EXTRACT;

BACTERIAL INFECTION; BACTERIUM; CARBOHYDRATE TOLERANCE; CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIABETES MELLITUS; DIAPHORESIS; DISEASE SEVERITY; DIURESIS; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG RESEARCH; DRUG SCREENING; DRUG SYNTHESIS; FEVER; FRUIT; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; GLUCOSURIA; GOUT; HEALTH STATUS; HUCKLEBERRY; HUMAN; HYPERGLYCEMIA; HYPERTHYROIDISM; INSULIN TREATMENT; LOW CARBOHYDRATE DIET; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; NONHUMAN; PANCREAS RESECTION; PARASITOSIS; PILL; PLANT LEAF; REVIEW; SKIN IRRITATION; STREPTOZOCIN DIABETES; SURVIVAL; TABLET; TEA; TYPHOID FEVER; URINARY TRACT INFECTION; VACCINIUM MYRTILLUS; WEIGHT GAIN; YEAST;

HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PLANT EXTRACTS; PLANT LEAVES; VACCINIUM MYRTILLUS;

EID: 77953063922     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.9402     Document Type: Review

References (59)

1. Allan FN (1972) Diabetes before and after insulin. Med Hist 16: 166-173.
2. Allen FM (1927a) Blueberry leaf extract. Physiologic and clinical properties in relation to carbohydrate metabolism. J Amer Med Assoc 89: 1577-1581.
3. Allen FM (1927b) Blueberry leaf extract. J Canad Med Assoc 17: 1539-1540.
4. Anon (1903) Reports and analyses and descriptions of new inventions in medicine, surgery, dietetics, and the allied sciences. Brit Med J Apr 25: 972.
5. Atta-Ur-Rahman, Zaman K (1989) Medicinal plants with hypoglycemic activity. J Ethnopharmacol 26: 1-55.
6. Baily CJ, Day C (1989)Traditional plant medicines as treatments of diabetes. Diabetes Care 12: 553-564.
7. Bernstein (1903) On the bilberry (Vaccinium myrtillus) as remedy in typhoid fever and other infectious diseases of the intestine. Brit Med J Feb,7: 306-308.
8. Bock H (1595) Kreütterbuch, darin unterscheidt, Nammen und Würkung der Kreütter [...]. Strassburg.
9. Braun CE, Rees FM (1935) Insulin-like materials from plant tissues. J Chem Educ 12: 453-458.
10. Buenz EJ, Schnepple DJ, Bauer BA, Elkin PL, Riddle JM, Motley TJ (2004) Techniques: Bioprospecting historical herbal texts by hunting for new leads in old tomes. Trends Pharmacol Sci 25: 494-498.
11. Carai MAM, Fantini N, Loi B, Colombo G, Riva A, Morazzoni P (2009) Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism. Diab Metab Syndr Obes Targets Ther 2: 145-153.
12. Cicero AF, Derosa G, Gaddi A (2004) What do herbalists suggest to diabetic patients in order to improve glycemic control? Evaluation of scientific evidence and potential risks. Acta Diabetol 41: 91-98. (Pubitemid 39304483)
13. Cignarella A, Nastasi M, Cavalli E, Puglisi L (1996) Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate. Thromb Res 84: 311-322. (Pubitemid 26417643)
14. Collip JB (1923) Glucokinin. A new hormone present in plant tissue. Preliminary paper. J Biol Chem 56: 513-543.
15. Davis W (1928) Copper, fits, legs, yeast, brains. The Science Newsletter 13 (No. 367), 245-246.
16. Dietering H (1938) Über die Wirkung von Heidelbeerblättern. Arch Exper Pathol Pharmakol 188: 500-513.
17. Edgar NK (1934) The blueberry. The pharmacology of neomyrtillin from blueberry leaf with a description of vaccinium caeserense. Complete analyses of leaf and fruit. The Gaw Printing Company, Pub, Jersey City. (Ph.D. thesis 1929).
18. Eppinger H, Mark E, Wagner RJ (1925) Weitere Beobachtungen über die Wirkung von aus Heidelbeerblättern hergestellten Präparaten (Myrthillin) auf pankreaslose Hunde. Klin Wschr 4: 1870-1871.
19. Frohne D (2002) Heilpflanzenlexikon. 7th ed. Stuttgart, pp. 556-557.
20. Galimard J (1939) Les Vacciniées et, en particulier, le Vaccinium Myrtillus L. en thérapeutique. Ph.D. thesis, Paris.
21. Hänsel R, Keller K, Rimpler H, Schneider G (eds.) (1996) Drogen P-Z. Hager's Handbuch der Pharmazeutischen Praxis, 5th ed., vol. 6, pp.1051-1067.
22. Helmstädter A (2007) Antidiabetic drugs used in Europe prior to the discovery of insulin. Pharmazie 62: 717-720.
23. Helmstädter A (2008) Syzygium cumini (L.) Skeels (Myrtaceae) against diabetes-125 years of research. Pharmazie 63: 91-101.
24. Helmstädter A (2009) Arzneimittelgeschichte: Antidiabetika vor Entdeckung des Insulins. Pharm Ztg 154: 3921-3926.
25. Helmstädter A (2010) Beans and diabetes-Phaseolus vulgaris preparations as antihyperglycemic agents. J Med Food, in print. (doi: 10.1089/jmf.2009.0002).
26. Holcomb B (1928) Myrtomel in diabetes mellitus, the results of its use. Northwest Med 27: 586-588.
27. Jorgensen PS, Lynn EV (1935) Vegetable extracts and blood sugar. J Am Pharm Assoc 24: 389-392.
28. Kaufmann M (1908) Ueber die Einwirkung von Medikamenten auf die Glykosurie der Diabetiker. Zschr Klin Med 48: 260-289, 436-490.
29. Kleiner IS (1959) Hypoglycemic agents-past and present. Clin Chem 5: 79-99.
30. Knorr (1892) Fluidextrakt aus Heidelbeerblättern gegen Zuckerkrankheit. Pharm Ztg 37: 619.
31. Kreitmair H (1947) Vaccinia Myrtillum, die Heidelbeere. Pharmazie 2: 219-222.
32. Kröger C (1951a) Die Heidelbeere, Vaccinium Myrtillus L. I. Chemie der Heidelbeerpflanze. Pharmazie 6: 211-217.
33. Kröger C (1951b) Die Heidelbeere, Vaccinium Myrtillus L. II. Pharmazie der Heidelbeere, Vaccinium myrtillus L. Pharmazie 6: 355-360.
34. LabbéH(1936) The vegetable insulinoides and their therapeutic indications. Can Med Assoc J 34: 141-144.
35. Lonitzer A (1679) Kreuterbuch. Ulm. Reprint Munich 1962.
36. Madaus G (1976-1979) Lehrbuch der biologischen Heilmittel. 3 vol. Reprint of the edition of 1938. Hildesheim /New York.
37. Mark RE, Wagner RJ (1925) Über die Beeinflussung alimentärer Hyperglykämie normaler Hunde durch die orale Verabreichung von Extrakten aus Foliis myrthilli. Klin Wschr 4: 1692-1693.
38. Matthioli PA (1598) Opera quae extant omnia [...]. Basel.
39. Medvei VC (1993) The History of Clinical Endocrinology. Carnforth and New York, p. 301.
40. Melzig MF, Funke I (2007) Pflanzliche alpha-Amylasehemmer-eine Möglichkeit zur Phytotherapie bei Diabetes mellitus Typ II? Wien Med Wschr 157: 320-324.
41. Merck E (1927) Jahresberichte 41: 182-183.
42. Morazzoni P, Bombardelli E (1996) Vaccinium myrtillus L. Fitoterapia 67: 3-29. (Pubitemid 26104665)
43. Oettel H (1936) Die Hydrochinonvergiftung. Naunyn-Schmiedeberg's Arch. Pharmacol 183: 319-362.
44. Petlevski R, Hadžija M, Slijepčević M, Juretić D (2001) Effect of 'antidiabetis' herbal preparation on serum glucose and fructosamine in NOD mice. J Ethnopharmacol 75: 181-184. (Pubitemid 32297731)
45. Pomp H (1936) Therapeutische Prüfung peroraler antidiabetischer Mittel. PhD thesis, Univ. Bonn.
46. Rathery MF, Levina L (1928) Myrtille et diabète (1). Bull Mém Soc Méd Hopitaux Paris 3. Ser. 52: 1758-1764.
47. Rau O, Wurglics M, Dingermann T, Abdel-Tawab M, Schubert-Zsilavecz M (2006) Screening of herbal extracts for activation of the human peroxisome proliferator activated receptor. Pharmazie 61: 952-956. (Pubitemid 44807270)
48. Riddle JM (2002) History as a tool in identifying "new" old drugs. Adv Exp Med Biol 505: 89-94.
49. Sawyer J (1903) The bilberry. Brit Med J Feb 28: 485-486.
50. Severinghaus EL (1928) Diabetes: The use of synthalin and myrtillin in the treatment. Wisconsin Med J 27: 488-491.
51. Shpiner LB (1928) The action of myrtillin in pancreatic insufficiency. Am J Physiol 84: 396-400.
52. Shpiner LB (1929) Blueberry leaf extract overdosage. Arch Int Med 44: 204-208.
53. Steffan B (1902) Ueber Glykosurie und deren Beeinflussung durch Medikamente. Ph.D. thesis München.
54. Watson EM (1928) Some observations on the effect of blueberry leaf extract in diabetes mellitus. Canadian Med Assoc J 19: 166-171.
55. Weil R(1892)Weitere Erfolge mit Heidelbeerkraut gegen Diabetes mellitus. Allg Med Central-Ztg 61: 1619-1620.
56. Wilder RM, Allan FN (1928, recte 1929) Synthalin, myrtomel, and glukhorment. Abstract 79th Annual Session of the American Medical Association Minneapolis, 1928. Coll Papers Mayo Clinic 20: 490.
57. Willstätter, R, Zollinger EH (1915) Über die Farbstoffe der Weintraube und der Heidelbeere. Justus Liebigs Annal Chem 408: 83-109.
58. Zareba G, Serradell N, Castañer R, Davies SL, Prous J, Mealy N (2005) Phytotherapies for diabetes. Drugs Future 30: 1253-1282.
59. Zedler JH (1735) Großes vollständiges Universal-Lexikon aller Wissenschaften und Künste (...) vol. 12, col. 1129-1131.